Jorge Gomez - Xylem Independent Director
| XYL Stock | USD 128.94 2.07 1.63% |
Director
Mr. Jorge M. Gomez is Independent Director of the Company. Mr. Gomez has served as the Chief Financial Officer of Cardinal Health, a global, integrated healthcare solutions company, since January 2018. Prior to his current role, he served as chief financial officer of Cardinal Healths Medical segment. Since joining Cardinal Health in 2006, Mr. Gomez has also served as chief financial officer of the Pharmaceutical segment, corporate treasurer and corporate controller. Previously, Mr. Gomez held positions at General Motors Corporationrationration, including executive and managerial posts in New York, Singapore, Belgium, and Brazil. Mr. Gomez has served on the Cardinal Health Foundation board, the Mount Carmel Health System Board of Trustees, the executive board of Red Oak Sourcing, the Business Advisory Council at Miami University, and the Dublin Food Pantry board. since 2019.
| Age | 53 |
| Tenure | 5 years |
| Address | 300 Water Street SE, Washington, DC, United States, 20003 |
| Phone | 202 869 9150 |
| Web | https://www.xylem.com |
Xylem Management Efficiency
The company has Return on Asset of 0.0443 % which means that on every $100 spent on assets, it made $0.0443 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0808 %, implying that it generated $0.0808 on every 100 dollars invested. Xylem's management efficiency ratios could be used to measure how well Xylem manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Xylem's Return On Tangible Assets are quite stable compared to the past year. Return On Assets is expected to rise to 0.07 this year, although the value of Return On Capital Employed will most likely fall to 0.04. At this time, Xylem's Debt To Assets are quite stable compared to the past year. Fixed Asset Turnover is expected to rise to 8.42 this year, although the value of Other Current Assets will most likely fall to about 159.6 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Ake Svensson | Parker Hannifin | 68 | |
| Michael Critelli | Eaton PLC | 71 | |
| Orlando Ashford | ITT Inc | 51 | |
| Gayla Delly | Flowserve | 61 | |
| Dorothy Thompson | Eaton PLC | 60 | |
| Eric Spiegel | Dover | 63 | |
| Arthur Golden | Emerson Electric | 74 | |
| Carl Christenson | IDEX Corporation | 61 | |
| Sandra Pianalto | Eaton PLC | 66 | |
| Sabrina Soussan | ITT Inc | 50 | |
| Susan Crown | Illinois Tool Works | 62 | |
| Stephen Wagner | Dover | 74 | |
| Bruce Smith | Smith AO | 71 | |
| Cynthia Warner | IDEX Corporation | 61 | |
| Candace Kendle | Emerson Electric | 73 | |
| John Garrison | Flowserve | 60 | |
| Robert Pragada | Eaton PLC | 52 | |
| Gregory Page | Eaton PLC | 69 | |
| David Parry | IDEX Corporation | 67 | |
| Timothy Powers | ITT Inc | 71 | |
| Mario Longhi | ITT Inc | 65 | |
Management Performance
| Return On Equity | 0.0808 | ||||
| Return On Asset | 0.0443 |
Xylem Inc Leadership Team
Elected by the shareholders, the Xylem's board of directors comprises two types of representatives: Xylem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Xylem. The board's role is to monitor Xylem's management team and ensure that shareholders' interests are well served. Xylem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Xylem's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Colin Sabol, Senior Vice President and President, Measurement & Control Solutions | ||
| Thomas Pettit, Senior Officer | ||
| Matthew Latino, Director - Investor Relations | ||
| Markos Tambakeras, Non-Executive Independent Chairman of the Board | ||
| Uday Yadav, Independent Director | ||
| Victoria Harker, Independent Director | ||
| Surya Mohapatra, Independent Director | ||
| Mark Morelli, Independent Director | ||
| William Grogan, Senior CFO | ||
| Steven Loranger, Independent Director | ||
| Curtis Crawford, Independent Director | ||
| Lila Tretikov, Independent Director | ||
| Jerome Peribere, Independent Director | ||
| Jorge Gomez, Independent Director | ||
| Robert Friel, Independent Chairman of the Board | ||
| Shuping Lu, President Asia | ||
| Kairus Tarapore, Chief Human Resource Officer, Senior Vice President | ||
| David Flinton, Senior VP and Chief Innovation, Technology & Products Officer, Acting President - Water Infrastructure and Europe Commercial Team | ||
| GeriMichelle McShane, Chief Accounting Officer, Vice President Controller | ||
| Matthew Pine, Senior Vice President and Presidentident - Applied Water Systems and Americas Commercial Team | ||
| Pak Leung, Senior Vice President and President - Emerging Markets | ||
| Claudia Toussaint, Chief Human Resource and Sustainability Officer, Senior Vice President, General Counsel, Company Secretary | ||
| JD Esq, Chief VP | ||
| Hayati Yarkadas, Senior Vice President and Presidentident - Water Infrastructure and Europe Commercial Team | ||
| Franz Cerwinka, Senior Vice President and President Emerging Markets | ||
| E Rajkowski, Chief Financial Officer, Senior Vice President | ||
| Sandra Rowland, Chief Financial Officer, Senior Vice President | ||
| John Kehoe, VP Officer | ||
| Jeanne BeliveauDunn, Independent Director | ||
| Patrick Decker, President, Chief Executive Officer, Director | ||
| Sten Jakobsson, Independent Director | ||
| Albert Cho, Senior Officer | ||
| Andrea Berg, Vice Relations | ||
| Dorothy Capers, Senior Vice President General Counsel |
Xylem Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Xylem a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0808 | ||||
| Return On Asset | 0.0443 | ||||
| Profit Margin | 0.1 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 31.94 B | ||||
| Shares Outstanding | 242.94 M | ||||
| Shares Owned By Insiders | 0.64 % | ||||
| Shares Owned By Institutions | 93.89 % | ||||
| Number Of Shares Shorted | 2.49 M | ||||
| Price To Earning | 64.49 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xylem Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xylem. If investors know Xylem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xylem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.413 | Dividend Share 1.41 | Earnings Share 3.48 | Revenue Per Share 34.788 | Quarterly Revenue Growth 0.013 |
The market value of Xylem Inc is measured differently than its book value, which is the value of Xylem that is recorded on the company's balance sheet. Investors also form their own opinion of Xylem's value that differs from its market value or its book value, called intrinsic value, which is Xylem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xylem's market value can be influenced by many factors that don't directly affect Xylem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xylem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xylem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xylem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.